Agenus Inc., a medical-phase biotechnology business, discovers and develops therapies to activate the human body's immune method against most cancers and bacterial infections in America and internationally. It offers Retrocyte Display screen, an antibody expression platform with the identification of absolutely human and humanized monoclonal antibo